TW202108116A - Sunscreen cosmetic composition having sebum absorbing ability - Google Patents

Sunscreen cosmetic composition having sebum absorbing ability Download PDF

Info

Publication number
TW202108116A
TW202108116A TW109114991A TW109114991A TW202108116A TW 202108116 A TW202108116 A TW 202108116A TW 109114991 A TW109114991 A TW 109114991A TW 109114991 A TW109114991 A TW 109114991A TW 202108116 A TW202108116 A TW 202108116A
Authority
TW
Taiwan
Prior art keywords
weight
composition
use according
acrylate
meth
Prior art date
Application number
TW109114991A
Other languages
Chinese (zh)
Inventor
林亨峻
朴貞銀
朴城逸
徐丙徽
Original Assignee
韓商愛茉莉太平洋股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 韓商愛茉莉太平洋股份有限公司 filed Critical 韓商愛茉莉太平洋股份有限公司
Publication of TW202108116A publication Critical patent/TW202108116A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0245Specific shapes or structures not provided for by any of the groups of A61K8/0241
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/064Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966Triazines or their condensed derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8117Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin

Abstract

The present disclosure relates to a cosmetic composition for improving the sebum-controlling ability of a sunscreen which comprises bowl-like non-porous microparticles comprising a polymer matrix in which bis-ethylhexyloxyphenol methoxylphenyl triazine is stabilized. The composition comprises hardly soluble bis-ethylhexyloxyphenol methoxylphenyl triazine in the form of bowl-like microparticles, and thus has high sebum absorption and shows a light and fresh feeling of use.

Description

具有皮脂吸收能力之防曬用化妝品組成物Sunscreen cosmetic composition with sebum absorption capacity

本揭露內容關於一種皮脂控制化妝品組成物。 相關申請之交互參照The present disclosure relates to a sebum control cosmetic composition. Cross-reference of related applications

本申請主張2019年5月15日在韓國提交的韓國專利申請案第10-2019-0057114號之優先權,此申請案之揭露內容被以引用的方式併入本文中。This application claims the priority of Korean Patent Application No. 10-2019-0057114 filed in Korea on May 15, 2019, and the disclosure of this application is incorporated herein by reference.

皮脂為自皮脂腺排出之分泌液,且包括膽固醇、脂肪酸及酯化合物。皮脂用以防止皮膚表面之乾燥,但可引起在臉上之油光或妝容斑駁。因此,已進行關於能夠控制皮膚皮脂量以便在防曬或化妝品組成物之情況下一整天維持啞光且光滑塗抹狀態之產品的許多研究。為了控制皮膚皮脂量,大多使用無孔粉末或多孔球形粉末。無孔球形粉末展現低皮脂吸收能力。在多孔粉末粒子之情況下,依靠高浸入量,皮脂吸收能力高。然而,此等多孔粉末粒子具有過大的表面積,從而導致在粒子基質中穩定的成分之高溶解可能性。此外,如與無孔粒子相比,此等多孔粉末粒子具有較低機械性質,以造成在混合製程(均質混合、高壓乳化劑或類似者)期間的粒子之破壞問題。Sebum is the secretion discharged from the sebaceous glands and includes cholesterol, fatty acids and ester compounds. Sebum is used to prevent the surface of the skin from drying out, but it can cause shiny or mottled makeup on the face. Therefore, many studies have been conducted on products that can control the amount of skin sebum so as to maintain a matte and smooth application state throughout the day in the case of sunscreens or cosmetic compositions. In order to control the amount of skin sebum, non-porous powders or porous spherical powders are mostly used. The non-porous spherical powder exhibits low sebum absorption capacity. In the case of porous powder particles, the sebum absorption capacity is high depending on the high immersion amount. However, these porous powder particles have an excessively large surface area, resulting in a high dissolution probability of stable components in the particle matrix. In addition, as compared with non-porous particles, these porous powder particles have lower mechanical properties to cause particle damage during the mixing process (homogeneous mixing, high-pressure emulsifier, or the like).

[發明所欲解決的問題][The problem to be solved by the invention]

待由本揭露內容解決之技術問題為提供一種包含微粒子之化妝品組成物,其具有改良之皮脂吸收能力及高耐久性,且可穩定地分散於油包水型或矽包水型化妝品組成物中。 [用於解決問題的技術手段]The technical problem to be solved by the present disclosure is to provide a cosmetic composition containing fine particles, which has improved sebum absorption capacity and high durability, and can be stably dispersed in a water-in-oil or water-in-silicon cosmetic composition. [Technical means used to solve the problem]

在一個一般態樣中,提供一種用於改良防曬品之皮脂控制能力之化妝品組成物,其包含碗狀無孔微粒子,此等碗狀無孔微粒子包含雙-乙基己氧苯酚甲氧苯基三嗪分散於其中之聚合物基質。 [發明的功效]In a general aspect, a cosmetic composition for improving the sebum control ability of sunscreens is provided, which comprises bowl-shaped non-porous particles, and these bowl-shaped non-porous particles include bis-ethylhexyloxyphenol methoxyphenyl The polymer matrix in which the triazine is dispersed. [Effect of Invention]

根據本揭露內容之實施例,根據本揭露內容之化妝品組成物包含呈碗狀微粒子之形式的雙-乙基己氧苯酚甲氧苯基三嗪,且因此可提供具有高皮脂吸收能力之化妝品組成物。微粒子將雙-乙基己氧苯酚甲氧苯基三嗪穩定地分散於油包水型或矽包水型化妝品組成物中,經由皮脂控制能力,在塗抹至皮膚後,經過長時間仍提供清爽使用感覺。此外,微粒子依靠皮脂吸收,在塗抹至皮膚後,引起極小的油膩感覺及黏性,且因此可防止細塵在皮膚上之吸附。According to the embodiments of the present disclosure, the cosmetic composition according to the present disclosure includes bis-ethylhexyloxyphenol methoxyphenyl triazine in the form of bowl-shaped particles, and therefore, a cosmetic composition with high sebum absorption capacity can be provided Things. The micro particles stably disperse bis-ethylhexyloxyphenol methoxyphenyl triazine in the water-in-oil or water-in-silicon cosmetic composition. Through the sebum control ability, it will provide freshness after a long time after being applied to the skin. Feeling of use. In addition, the microparticles rely on sebum to absorb, causing minimal greasy feeling and stickiness after being applied to the skin, and thus can prevent the adsorption of fine dust on the skin.

現將在下文參看隨附圖式更充分地描述例示性實施例。然而,本揭露內容可以許多不同形式體現,且不應被解釋為限於本文中闡述之例示性實施例。將顯而易見的是,提供此等例示性實施例,使得本揭露內容將完整,且易於由熟習此項技術者理解。此外,熟習此項技術者將顯而易見,在不脫離如在以下申請專利範圍中定義的本揭露內容之精神及範疇之情況下,可進行各種改變及修改。Exemplary embodiments will now be described more fully below with reference to the accompanying drawings. However, the present disclosure can be embodied in many different forms, and should not be construed as being limited to the exemplary embodiments set forth herein. It will be obvious that these exemplary embodiments are provided so that the content of this disclosure will be complete and easy to understand by those skilled in the art. In addition, it will be obvious to those familiar with the technology that various changes and modifications can be made without departing from the spirit and scope of the disclosure as defined in the scope of the following patent applications.

在一個態樣中,提供一種用於改良防曬品之皮脂控制能力之化妝品組成物。組成物可包含碗狀無孔微粒子,其包含雙-乙基己氧苯酚甲氧苯基三嗪分散於其中之聚合物基質,作為活性成分。本文中,雙-乙基己氧苯酚甲氧苯基三嗪並不交聯至聚合物基質、特別是聚合交聯之結構內,但以近分子單元之形式均質地分散。In one aspect, a cosmetic composition for improving the sebum control ability of sunscreens is provided. The composition may include bowl-shaped non-porous microparticles, which include a polymer matrix in which bis-ethylhexyloxyphenol methoxyphenyltriazine is dispersed as an active ingredient. In this context, bis-ethylhexyloxyphenol methoxyphenyl triazine is not cross-linked into the polymer matrix, especially the polymerized cross-linked structure, but is homogeneously dispersed in the form of near-molecular units.

在另一態樣中,提供包含雙-乙基己氧苯酚甲氧苯基三嗪分散於其中之聚合物基質的碗狀無孔微粒子用於製備用於改良防曬品之皮脂控制能力之組成物之用途。在再一態樣中,提供一種用於改良防曬品之皮脂控制能力之方法,包含以下步驟:將包含雙-乙基己氧苯酚甲氧苯基三嗪分散於其中之聚合物基質的有效量之碗狀無孔微粒子施予至需要其之主體。在再一態樣中,提供碗狀無孔微粒子,其包含雙-乙基己氧苯酚甲氧苯基三嗪分散於其中之聚合物基質,作為用於在用於改良防曬品之皮脂控制能力之組成物中使用的活性成分。在再一態樣中,提供碗狀無孔微粒子,其包含雙-乙基己氧苯酚甲氧苯基三嗪分散於其中之聚合物基質,用於在防曬品之皮脂控制能力之改良中使用。在又一態樣中,提供碗狀無孔微粒子之非治療性用途,碗狀無孔微粒子包含雙-乙基己氧苯酚甲氧苯基三嗪分散於其中之聚合物基質,作為用於改良防曬品之皮脂控制能力之活性成分。In another aspect, a bowl-shaped non-porous microparticle containing a polymer matrix in which bis-ethylhexyloxyphenol methoxyphenyl triazine is dispersed is provided for preparing a composition for improving the sebum control ability of sunscreens The purpose. In another aspect, a method for improving the sebum control ability of sunscreens is provided, which comprises the following steps: an effective amount of a polymer matrix containing bis-ethylhexyloxyphenol methoxyphenyltriazine dispersed therein The bowl-shaped non-porous particles are applied to the body in need. In yet another aspect, a bowl-shaped non-porous microparticle is provided, which contains a polymer matrix in which bis-ethylhexyloxyphenol methoxyphenyl triazine is dispersed, as used for improving the sebum control ability of sunscreens. The active ingredient used in the composition. In another aspect, a bowl-shaped non-porous microparticle is provided, which contains a polymer matrix in which bis-ethylhexyloxyphenol methoxyphenyl triazine is dispersed, for use in the improvement of the sebum control ability of sunscreens . In another aspect, a non-therapeutic use of bowl-shaped non-porous particles is provided. The bowl-shaped non-porous particles comprise a polymer matrix in which bis-ethylhexyloxyphenol methoxyphenyl triazine is dispersed as a modified Active ingredient for the sebum control ability of sunscreens.

雙-乙基己氧苯酚甲氧苯基三嗪之另一化學名稱稱作2,4-雙[4-(2-乙基己氧基)-2-羥苯基]-6-(4-甲氧苯基)-1,3,5-三嗪,亦被稱作Bemotrininol,且具有CAS編號187393-00-6。舉例而言,雙-乙基己氧苯酚甲氧苯基三嗪可作為Tinosorb S® 購自BASF。雖然雙-乙基己氧苯酚甲氧苯基三嗪作為同時防護UVA及UVB之有機防曬劑而為人所知,但其對溶劑具有差的溶解度,且因此不利之處在於,其需溶解於具有高極性之油(諸如烷基苯甲酸酯)等中後,應用至油相。此油通常展現難以忍受之使用感覺且油膩。此外,雙-乙基己氧苯酚甲氧苯基三嗪對基於矽酮之油具有極低溶解度。因此,當將雙-乙基己氧苯酚甲氧苯基三嗪應用至具有矽酮作為外側相(outer phase)之調配物時,歸因於沈澱之問題,其可僅少量地併入。因此,存在不可能獲得足夠防曬效果之問題。Another chemical name for bis-ethylhexyloxyphenol methoxyphenyl triazine is 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4- Methoxyphenyl)-1,3,5-triazine, also known as Bemotrininol, has the CAS number 187393-00-6. For example, bis-ethylhexyloxyphenol methoxyphenyl triazine is available as Tinosorb S ® from BASF. Although bis-ethylhexyloxyphenol methoxyphenyl triazine is known as an organic sunscreen that protects both UVA and UVB, it has poor solubility in solvents, and the disadvantage is that it needs to be dissolved in Highly polar oils (such as alkyl benzoate), etc., are applied to the oil phase. This oil usually exhibits an unbearable feeling of use and is greasy. In addition, bis-ethylhexyloxyphenol methoxyphenyl triazine has extremely low solubility for silicone-based oils. Therefore, when bis-ethylhexyloxyphenol methoxyphenyl triazine is applied to a formulation having silicone as an outer phase, it can be incorporated in only a small amount due to the problem of precipitation. Therefore, there is a problem that it is impossible to obtain sufficient sun protection effect.

在此等情況下,本揭露內容之發明者已進行了集中式研究來製備呈碗狀微粒子之形式的雙-乙基己氧苯酚甲氧苯基三嗪,使得其可穩定地分散於無極性油之調配物中。結果,吾人已發現,此等微粒子展現優異之皮脂吸收能力,且當將其塗抹至皮膚時,會吸收自皮膚分泌之皮脂,且因此可有效地控制保留於皮膚表面上之皮脂。本揭露內容是基於此發現。Under these circumstances, the inventor of the present disclosure has conducted intensive research to prepare bis-ethylhexyloxyphenol methoxyphenyl triazine in the form of bowl-shaped microparticles, so that it can be stably dispersed in non-polar In the formulation of oil. As a result, we have found that these fine particles exhibit excellent sebum absorption capacity, and when they are applied to the skin, they absorb sebum secreted from the skin, and thus can effectively control the sebum remaining on the skin surface. The content of this disclosure is based on this discovery.

如本文中使用,術語「碗狀」涵蓋任何凹形碗或容器形狀(與內部凹陷度無關),或外部碗形狀。舉例而言,碗狀形狀可為圓凹形碗形狀,更特定言之,半球形凹形碗形狀。隨著內部凹容積之比率增大,微粒子之碗狀形狀可提供較高皮脂吸收性。舉例而言,此等微粒子可具有0.5 mL/g至1 mL/g之皮脂吸收性。此等微粒子可具有1.0 mL/g至1.5 mL/g之皮脂浸入量。如本文中使用,術語「無孔」指粒子在其中不具有孔或孔隙,且此等粒子可具有0或大致0之表面孔隙率。根據本揭露內容,如與球形無孔微粒子相比,依靠內部凹形空間,碗狀無孔微粒子之使用可提供改良之皮脂吸收性。因此,當將碗狀無孔微粒子塗抹至皮膚時,其可吸收或吸附存在於皮膚上之皮脂,以提供啞光且清爽之使用感覺。因此,可藉由控制皮脂來將塗抹至皮膚之化妝品組成物長時間地保留,且可防止空氣中的細塵之吸附。根據本揭露內容之一實施例,碗狀微粒子無孔,且因此如與習知多孔微粒子相比,具有較高粒子耐久性,且可在調配物中穩定地分散幾乎不可溶解之雙-乙基己氧苯酚甲氧苯基三嗪。更特定言之,如與球形微粒子相比,根據本揭露內容之一實施例的碗狀無孔微粒子具有較高皮脂吸收性,且如與多孔微粒子相比,具有較低皮脂吸收性。因此,碗狀無孔微粒子可在皮膚上吸收足夠量之皮脂,同時防止皮膚乾燥,且可提供啞光使用感覺。As used herein, the term "bowl shape" encompasses any concave bowl or container shape (regardless of inner concavity), or outer bowl shape. For example, the bowl shape may be a round concave bowl shape, more specifically, a hemispherical concave bowl shape. As the ratio of the internal concave volume increases, the bowl-like shape of the particles can provide higher sebum absorption. For example, these microparticles may have a sebum absorbency of 0.5 mL/g to 1 mL/g. These fine particles may have a sebum infiltration amount of 1.0 mL/g to 1.5 mL/g. As used herein, the term "non-porous" refers to particles having no pores or pores therein, and such particles may have a surface porosity of zero or approximately zero. According to the present disclosure, compared with spherical non-porous particles, the use of bowl-shaped non-porous particles can provide improved sebum absorption by virtue of the internal concave space. Therefore, when the bowl-shaped non-porous particles are applied to the skin, they can absorb or absorb sebum present on the skin to provide a matte and refreshing feeling of use. Therefore, by controlling sebum, the cosmetic composition applied to the skin can be retained for a long time, and the adsorption of fine dust in the air can be prevented. According to an embodiment of the present disclosure, the bowl-shaped microparticles are non-porous, and therefore, have higher particle durability compared with the conventional porous microparticles, and can stably disperse the almost insoluble bis-ethyl in the formulation Hexoxyphenol methoxyphenyl triazine. More specifically, as compared with spherical particles, the bowl-shaped non-porous particles according to an embodiment of the present disclosure have higher sebum absorption and, as compared with porous particles, lower sebum absorption. Therefore, the bowl-shaped non-porous particles can absorb a sufficient amount of sebum on the skin, while preventing the skin from drying out, and can provide a matte feeling of use.

根據本揭露內容之一實施例,微粒子可具有1 μm至10 μm之平均直徑,但不限於此,只要其可穩定地分散於組成物調配物中,同時在其中包含高含量之雙-乙基己氧苯酚甲氧苯基三嗪。微粒子之平均直徑為組成物中包含的粒子之平均值,且經由流體動力學體積判定,其限制性條件為,粒子為球形。特定言之,將30 mL等中子素(isotone)(Beckman Coulter)引入至100 mL容器,且將少量微粒子及分散劑溶液(10%之Triton X-100)添加至容器。接著,藉由150 W超音波振盪器分散所得溶液,且藉由使用Multisizer 4(Beckman Coulter)來進行粒徑分析。將分析結果展示為中值(d50 3.5 μm至5.5 μm),精確至十分之一單位。更特定言之,此等微粒子可具有1 μm或更大、2 μm或更大、3 μm或更大、4 μm或更大、5 μm或更大、6 μm或更大、7 μm或更大、8 μm或更大、9 μm或更大、或9.9 μm或更大,及10 μm或更小、9 μm或更小、8 μm或更小、7 μm或更小、6 μm或更小、5 μm或更小、4 μm或更小、3 μm或更小、2 μm或更小或1.1 μm或更小之平均直徑。具體言之,此等微粒子可具有1 μm至8 μm且更具體言之為2 μm至6 μm之平均直徑。According to an embodiment of the present disclosure, the microparticles may have an average diameter of 1 μm to 10 μm, but it is not limited to this, as long as they can be stably dispersed in the composition formulation and contain a high content of bis-ethyl Hexoxyphenol methoxyphenyl triazine. The average diameter of the microparticles is the average value of the particles contained in the composition, and is determined by hydrodynamic volume, and the limiting condition is that the particles are spherical. Specifically, 30 mL isotone (Beckman Coulter) was introduced into a 100 mL container, and a small amount of microparticles and a dispersant solution (10% Triton X-100) were added to the container. Next, the resulting solution was dispersed by a 150 W ultrasonic oscillator, and particle size analysis was performed by using Multisizer 4 (Beckman Coulter). Display the analysis result as a median value (d 50 3.5 μm to 5.5 μm), accurate to one-tenth of a unit. More specifically, these fine particles may have 1 μm or more, 2 μm or more, 3 μm or more, 4 μm or more, 5 μm or more, 6 μm or more, 7 μm or more. Large, 8 μm or more, 9 μm or more, or 9.9 μm or more, and 10 μm or less, 9 μm or less, 8 μm or less, 7 μm or less, 6 μm or more The average diameter is small, 5 μm or less, 4 μm or less, 3 μm or less, 2 μm or less, or 1.1 μm or less. Specifically, these fine particles may have an average diameter of 1 μm to 8 μm, and more specifically, 2 μm to 6 μm.

根據本揭露內容之一實施例,雙-乙基己氧苯酚甲氧苯基三嗪未交聯至聚合物基質之聚合交聯結構內,但以近分子單元之形式均質地分散於由交聯結構形成之網狀結構中。特定言之,聚合交聯結構可包含雙-乙基己氧苯酚甲氧苯基三嗪,及可聚合單體與多官能交聯劑之聚合產物。更特定言之,可藉由使用包含雙-乙基己氧苯酚甲氧苯基三嗪、可聚合單體及多官能交聯劑中之所有的油相之分散聚合來製備微粒子。According to an embodiment of the present disclosure, bis-ethylhexyloxyphenol methoxyphenyl triazine is not cross-linked into the polymerized cross-linked structure of the polymer matrix, but is homogeneously dispersed in the cross-linked structure in the form of near-molecular units. In the formed network structure. Specifically, the polymerized cross-linking structure may include bis-ethylhexyloxyphenol methoxyphenyl triazine, and the polymerization product of a polymerizable monomer and a multifunctional cross-linking agent. More specifically, the microparticles can be prepared by dispersion polymerization using all of the oil phase including bis-ethylhexyloxyphenol methoxyphenyltriazine, polymerizable monomers, and multifunctional crosslinking agents.

根據本揭露內容之一實施例,可取決於其中含有的雙-乙基己氧苯酚甲氧苯基三嗪之比率獲得呈不同形狀之微粒子。在此上下文中,根據本揭露內容之一實施例的碗狀微粒子可包含基於微粒子之總重量的20重量%至30重量%之量的雙-乙基己氧苯酚甲氧苯基三嗪。更特定言之,碗狀微粒子可包含基於微粒子之總重量的20重量%或更大、21重量%或更大、22重量%或更大、23重量%或更大、24重量%或更大、25重量%或更大、26重量%或更大、27重量%或更大、28重量%或更大、29重量%或更大、或29.9重量%或更大,及30重量%或更小、29重量%或更小、28重量%或更小、27重量%或更小、26重量%或更小、25重量%或更小、24重量%或更小、23重量%或更小、22重量%或更小、21重量%或更小、或20.1重量%或更小之量的雙-乙基己氧苯酚甲氧苯基三嗪。According to an embodiment of the present disclosure, particles with different shapes can be obtained depending on the ratio of bis-ethylhexyloxyphenol methoxyphenyltriazine contained therein. In this context, the bowl-shaped microparticles according to an embodiment of the present disclosure may include bis-ethylhexyloxyphenol methoxyphenyltriazine in an amount of 20% to 30% by weight based on the total weight of the microparticles. More specifically, the bowl-shaped microparticles may contain 20% by weight or more, 21% by weight or more, 22% by weight or more, 23% by weight or more, 24% by weight or more based on the total weight of the microparticles. , 25% by weight or more, 26% by weight or more, 27% by weight or more, 28% by weight or more, 29% by weight or more, or 29.9% by weight or more, and 30% by weight or more Small, 29% by weight or less, 28% by weight or less, 27% by weight or less, 26% by weight or less, 25% by weight or less, 24% by weight or less, 23% by weight or less , 22% by weight or less, 21% by weight or less, or 20.1% by weight or less of bis-ethylhexyloxyphenol methoxyphenyltriazine.

根據本揭露內容之一實施例,可聚合單體可為無特定限制之任何自由基可聚合單體,只要其可與多官能交聯單體共聚。特定言之,可聚合單體可為含有一個乙烯基團之自由基可聚合單體。舉例而言,可聚合單體可包含選自由以下各者組成之群組的至少一種自由基可聚合單體:選自由苯乙烯、甲基苯乙烯、乙基苯乙烯、氟苯乙烯、氯苯乙烯及乙烯基甲苯組成之群組的至少一種芳族乙烯基單體;及選自由甲基(甲基)丙烯酸酯、乙基(甲基)丙烯酸酯、丁基(甲基)丙烯酸酯、辛基(甲基)丙烯酸酯、硬脂醯(甲基)丙烯酸酯、苯甲基(甲基)丙烯酸酯及縮水甘油基(甲基)丙烯酸酯組成之群組的至少一種丙烯酸乙烯基單體。根據本揭露內容之一實施例,多官能交聯劑可為能夠交聯可聚合單體之任何單體,無特定限制。特定言之,交聯劑可為含有兩個或更多個乙烯基團之交聯劑。舉例而言,交聯劑可包含選自由以下各者組成之群組的至少一種交聯劑:二乙烯基苯、乙二醇二甲基丙烯酸酯、二乙二醇二甲基丙烯酸酯、三乙二醇二甲基丙烯酸酯、三甲基丙烷三甲基丙烯酸酯、1,3-丁二醇二甲基丙烯酸酯、1,6-己二醇二甲基丙烯酸酯及三(甲基)丙烯酸酯。According to an embodiment of the present disclosure, the polymerizable monomer can be any radical polymerizable monomer without specific limitations, as long as it can be copolymerized with a multifunctional crosslinking monomer. Specifically, the polymerizable monomer may be a radical polymerizable monomer containing a vinyl group. For example, the polymerizable monomer may include at least one radical polymerizable monomer selected from the group consisting of: styrene, methylstyrene, ethylstyrene, fluorostyrene, chlorobenzene At least one aromatic vinyl monomer in the group consisting of ethylene and vinyl toluene; and selected from methyl (meth)acrylate, ethyl (meth)acrylate, butyl (meth)acrylate, octyl At least one acrylic vinyl monomer in the group consisting of methyl (meth)acrylate, stearyl (meth)acrylate, benzyl (meth)acrylate, and glycidyl (meth)acrylate. According to an embodiment of the present disclosure, the multifunctional crosslinking agent can be any monomer capable of crosslinking polymerizable monomers, and there is no specific limitation. Specifically, the crosslinking agent may be a crosslinking agent containing two or more vinyl groups. For example, the crosslinking agent may include at least one crosslinking agent selected from the group consisting of: divinylbenzene, ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, Ethylene glycol dimethacrylate, trimethylpropane trimethacrylate, 1,3-butanediol dimethacrylate, 1,6-hexanediol dimethacrylate and tris(meth) Acrylate.

根據本揭露內容之一實施例,聚合產物可為藉由甲基甲基丙烯酸酯與乙二醇二甲基丙烯酸酯之間的自由基聚合形成之甲基甲基丙烯酸酯交聯聚合物,且可具有隨機網狀結構。According to an embodiment of the present disclosure, the polymerization product may be a methacrylate cross-linked polymer formed by free radical polymerization between methacrylate and ethylene glycol dimethacrylate, and Can have a random network structure.

可聚合單體與多官能交聯劑之重量比可取決於所要的交聯程度而變化,無特定限制。舉例而言,多官能交聯劑可按基於可聚合單體之100重量%的0.1重量%至100重量%、特定言之1重量%至50重量%且更特定言之1重量%至25重量%的量摻合。The weight ratio of the polymerizable monomer to the multifunctional crosslinking agent can vary depending on the desired degree of crosslinking, and is not particularly limited. For example, the multifunctional crosslinking agent can be based on 100% by weight of the polymerizable monomer from 0.1% to 100% by weight, specifically from 1% to 50% by weight, and more specifically from 1% to 25% by weight. % Blended.

根據本揭露內容之一實施例,取決於無特定限制之使用目的,組成物可包含任何量之微粒子。著眼於有效地控制皮脂,組成物可包含基於組成物之總重量的1重量%至50重量%之量的微粒子,特定言之,1重量%或更大、2重量%或更大、3重量%或更大、4重量%或更大、5重量%或更大、6重量%或更大、7重量%或更大、8重量%或更大、9重量%或更大、10重量%或更大、11重量%或更大、12重量%或更大、13重量%或更大、14重量%或更大、15重量%或更大、16重量%或更大、17重量%或更大、18重量%或更大、19重量%或更大、20重量%或更大、21重量%或更大、22重量%或更大、23重量%或更大、24重量%或更大、25重量%或更大、26重量%或更大、27重量%或更大、28重量%或更大、29重量%或更大、30重量%或更大、31重量%或更大、32重量%或更大、33重量%或更大、34重量%或更大、35重量%或更大、36重量%或更大、37重量%或更大、38重量%或更大、39重量%或更大、40重量%或更大、41重量%或更大、42重量%或更大、43重量%或更大、44重量%或更大、45重量%或更大、46重量%或更大、47重量%或更大、48重量%或更大、49重量%或更大、或49.9重量%或更大,及50重量%或更小、49重量%或更小、48重量%或更小、47重量%或更小、46重量%或更小、45重量%或更小、44重量%或更小、43重量%或更小、42重量%或更小、41重量%或更小、40重量%或更小、39重量%或更小、38重量%或更小、37重量%或更小、36重量%或更小、35重量%或更小、34重量%或更小、33重量%或更小、32重量%或更小、31重量%或更小、30重量%或更小、29重量%或更小、28重量%或更小、27重量%或更小、26重量%或更小、25重量%或更小、24重量%或更小、23重量%或更小、22重量%或更小、21重量%或更小、20重量%或更小、19重量%或更小、18重量%或更小、17重量%或更小、16重量%或更小、15重量%或更小、14重量%或更小、13重量%或更小、12重量%或更小、11重量%或更小、10重量%或更小、9重量%或更小、8重量%或更小、7重量%或更小、6重量%或更小、5重量%或更小、4重量%或更小、3重量%或更小、或2重量%或更小。According to an embodiment of the present disclosure, the composition may contain any amount of fine particles depending on the purpose of use without specific restrictions. Focusing on effective control of sebum, the composition may contain fine particles in an amount of 1% to 50% by weight based on the total weight of the composition, specifically, 1% by weight or more, 2% by weight or more, and 3% by weight % Or greater, 4% by weight or greater, 5% by weight or greater, 6% by weight or greater, 7% by weight or greater, 8% by weight or greater, 9% by weight or greater, 10% by weight Or greater, 11% by weight or greater, 12% by weight or greater, 13% by weight or greater, 14% by weight or greater, 15% by weight or greater, 16% by weight or greater, 17% by weight or Greater, 18% by weight or greater, 19% by weight or greater, 20% by weight or greater, 21% by weight or greater, 22% by weight or greater, 23% by weight or greater, 24% by weight or greater Large, 25% by weight or greater, 26% by weight or greater, 27% by weight or greater, 28% by weight or greater, 29% by weight or greater, 30% by weight or greater, 31% by weight or greater , 32% by weight or greater, 33% by weight or greater, 34% by weight or greater, 35% by weight or greater, 36% by weight or greater, 37% by weight or greater, 38% by weight or greater, 39% by weight or greater, 40% by weight or greater, 41% by weight or greater, 42% by weight or greater, 43% by weight or greater, 44% by weight or greater, 45% by weight or greater, 46 % By weight or greater, 47% by weight or greater, 48% by weight or greater, 49% by weight or greater, or 49.9% by weight or greater, and 50% by weight or less, 49% by weight or less, 48% by weight or less, 47% by weight or less, 46% by weight or less, 45% by weight or less, 44% by weight or less, 43% by weight or less, 42% by weight or less, 41 % By weight or less, 40% by weight or less, 39% by weight or less, 38% by weight or less, 37% by weight or less, 36% by weight or less, 35% by weight or less, 34% by weight % Or less, 33% by weight or less, 32% by weight or less, 31% by weight or less, 30% by weight or less, 29% by weight or less, 28% by weight or less, 27% by weight Or less, 26% by weight or less, 25% by weight or less, 24% by weight or less, 23% by weight or less, 22% by weight or less, 21% by weight or less, 20% by weight or Less, 19% by weight or less, 18% by weight or less, 17% by weight or less, 16% by weight or less, 15% by weight or less, 14% by weight or less, 13% by weight or less Small, 12% by weight or less, 11% by weight or less, 10% by weight or less, 9% by weight or less, 8% by weight or less, 7% by weight or less, 6% by weight or less , 5% by weight or less, 4% by weight or less, 3% by weight or less, or 2% by weight or less.

根據本揭露內容之一實施例,組成物可為油包水(W/O)型組成物。更特定言之,組成物可為矽包水(W/S)型組成物。如本文中使用,術語「W/S型」意謂包含油(基本上包含矽酮油,作為連續相)及在其中之含水分散相的乳劑。換言之,W/S型化妝品組成物意謂含水內部水相分散於含矽酮油之外部油相中之狀態的乳劑。根據本揭露內容,如與藉由使用雙-乙基己氧苯酚甲氧苯基三嗪之穩定化之微粒子的有關技術相比,可按較高含量將雙-乙基己氧苯酚甲氧苯基三嗪施加至W/O型或W/S型組成物之外部相。According to an embodiment of the present disclosure, the composition may be a water-in-oil (W/O) type composition. More specifically, the composition may be a water-in-silica (W/S) type composition. As used herein, the term "W/S type" means an emulsion comprising oil (essentially comprising silicone oil as a continuous phase) and an aqueous dispersed phase therein. In other words, the W/S type cosmetic composition means an emulsion in a state where an aqueous inner water phase is dispersed in an outer oil phase containing silicone oil. According to the present disclosure, compared with the related technology of stabilized fine particles by using bis-ethylhexyloxyphenol methoxyphenyl triazine, bis-ethylhexyloxyphenol methoxybenzene can be reduced in a higher content. The triazine is applied to the external phase of the W/O type or W/S type composition.

根據本揭露內容之一實施例的W/S型化妝品組成物可包含基於組成物之總重量的0重量%至1重量%之量的具有選自以下各者之至少一種極性官能基團之極性油:羧基(COO)、酮基(CO)及羥基(OH)。舉例而言,極性油可包含鯨蠟醇乙基己酸酯、辛基十二醇肉豆蔻酸酯、二-C12-13烷基順丁烯二酸酯、季戊四醇四異硬脂酸酯、季戊四醇四乙基己酸酯、二異硬脂醇順丁烯二酸酯、棕櫚酸異丙酯、C12-C15烷基苯甲酸酯、碳酸二辛酯、二辛基醚及2-辛基十二烷醇。The W/S type cosmetic composition according to an embodiment of the present disclosure may include a polarity having at least one polar functional group selected from the following in an amount of 0% to 1% by weight based on the total weight of the composition Oil: carboxyl (COO), ketone (CO) and hydroxyl (OH). For example, the polar oil may include cetyl ethyl hexanoate, octyldodecanol myristate, di-C12-13 alkyl maleate, pentaerythritol tetraisostearate, pentaerythritol Tetraethylhexanoate, diisostearyl maleate, isopropyl palmitate, C12-C15 alkyl benzoate, dioctyl carbonate, dioctyl ether and 2-octyldecanoate Dialkyl alcohol.

根據本發明之一實施例的W/S型組成物可包含選自以下各者之至少一種基於矽酮之油:二甲基矽氧烷、環甲基矽氧烷、苯基三甲基矽氧烷、聚二甲基矽氧烷、甲基苯基聚矽氧烷、甲基苯基聚矽氧烷、環聚甲基矽氧烷、八甲基環四矽氧烷、十甲基環五矽氧烷、十二甲基環六矽氧烷、十四甲基六矽氧烷及八甲基三矽氧烷。根據本揭露內容之一實施例,組成物可包含基於組成物之總重量的15重量%至60重量%、特定言之15重量%至50重量%且更特定言之20重量%至40重量%之量的基於矽酮之油。根據本揭露內容之一實施例,組成物可其餘包含水。在根據本揭露內容之一實施例的W/S型化妝品組成物中,組成物可進一步包含基於矽酮之介面活性劑,其包含聚乙二醇(PEG)、聚丙二醇(PPG)及聚甘油基團中之至少一者。特定言之,著眼於包含雙-乙基己氧苯酚甲氧苯基三嗪之微粒子之穩定分散及防止呈晶體之形式的雙-乙基己氧苯酚甲氧苯基三嗪在介面處之沈積,根據本揭露內容之一實施例的組成物可使用添加有PEG的基於矽酮之介面活性劑。添加有PEG的基於矽酮之介面活性劑之特定實例可包含PEG/PPG-18/18二甲基矽氧烷(環五矽氧烷及PEG/PPG-18/18二甲基矽氧烷)、PEG-30二聚羥基硬脂酸酯、PEG-7二甲基矽氧烷、PEG-10二甲基矽氧烷、環五矽氧烷/PEG.PPG-19.19二甲基矽氧烷、山梨糖醇異硬脂酸酯、月桂基PEG.PPG-18.18甲基矽氧烷、鯨蠟基PEG.PPG-10.1二甲基矽氧烷、月桂基PEG-9聚二甲基矽氧乙基二甲基矽氧烷或類似物。此外,根據本揭露內容之一實施例的組成物可使用以上提到之添加有PEG的基於矽酮之介面活性劑中之至少一者,但不限於此。更特定言之,添加有PEG的基於矽酮之介面活性劑可為具有1至6之親水親油平衡值(hydrophile-lipophile balance;HLB)的非離子介面活性劑。舉例而言,可包含基於組成物之總重量的0.01重量%至10重量%、特定言之1重量%至8重量%且更特定言之3重量%至6重量%的量之介面活性劑。當包含小於0.01重量%之量之介面活性劑時,微粒子之可分散性可降級。當包含大於10重量%之量之介面活性劑時,可使黏性降低使用之清爽感。The W/S type composition according to an embodiment of the present invention may include at least one silicone-based oil selected from the following: dimethylsiloxane, cyclomethicone, phenyltrimethicone Oxyane, polydimethylsiloxane, methyl phenyl polysiloxane, methyl phenyl polysiloxane, cyclomethicone, octamethyl cyclotetrasiloxane, decamethyl ring Pentasiloxane, dodecamethylcyclohexasiloxane, tetradecamethylhexasiloxane and octamethyltrisiloxane. According to an embodiment of the present disclosure, the composition may include 15% to 60% by weight, specifically 15% to 50% by weight, and more specifically 20% to 40% by weight based on the total weight of the composition The amount of silicone-based oil. According to an embodiment of the present disclosure, the composition may remain water. In the W/S type cosmetic composition according to an embodiment of the present disclosure, the composition may further include a silicone-based surfactant, which includes polyethylene glycol (PEG), polypropylene glycol (PPG) and polyglycerin At least one of the groups. Specifically, focus on the stable dispersion of microparticles containing bis-ethylhexyloxyphenol methoxyphenyltriazine and prevent the deposition of bis-ethylhexyloxyphenol methoxyphenyltriazine in the form of crystals on the interface The composition according to an embodiment of the present disclosure may use a silicone-based surfactant with PEG added. Specific examples of PEG-added silicone-based interface active agents may include PEG/PPG-18/18 dimethylsiloxane (cyclopentasiloxane and PEG/PPG-18/18 dimethylsiloxane) , PEG-30 dipolyhydroxystearate, PEG-7 dimethylsiloxane, PEG-10 dimethylsiloxane, cyclopentasiloxane/PEG.PPG-19.19 dimethylsiloxane, Sorbitol Isostearate, Lauryl PEG.PPG-18.18 Methylsiloxane, Cetyl PEG.PPG-10.1 Dimethicone, Lauryl PEG-9 Polydimethylsiloxane Dimethylsiloxane or similar. In addition, the composition according to an embodiment of the present disclosure may use at least one of the above-mentioned silicone-based interface active agents added with PEG, but is not limited thereto. More specifically, the silicone-based interfacial active agent added with PEG may be a non-ionic interfacial active agent having a hydrophile-lipophile balance (HLB) of 1 to 6. For example, the surfactant may be included in an amount of 0.01% to 10% by weight, specifically 1% to 8% by weight, and more specifically 3% to 6% by weight based on the total weight of the composition. When the surfactant is contained in an amount of less than 0.01% by weight, the dispersibility of the microparticles may be degraded. When the surfactant is contained in an amount greater than 10% by weight, the viscosity can be reduced and the refreshing feeling of use can be reduced.

根據本揭露內容之一實施例的化妝品組成物可用化妝業或皮膚學上可接受之介質或基底來調配。此覆蓋適合於局部塗抹之任何調配物,且可以溶液、凝膠、固體、無水按摩產品、乳劑(藉由在水相、懸浮液、微乳劑、微膠囊、微粒或離子(脂質體)及非離子香粉分散劑中分散油相獲得)之形式提供,或提供為乳膏、表皮、乳液、粉末、油膏、噴霧或遮瑕棒。此外,化妝品組成物可以泡沫或氣溶膠組成物(進一步包含壓縮推進劑)之形式使用。此等調配物可藉由熟習此項技術者通常已知之方法來獲得。The cosmetic composition according to an embodiment of the present disclosure can be formulated with a medium or substrate that is acceptable for cosmetics or dermatology. This covering is suitable for any formulations for topical application, and can be used in solutions, gels, solids, anhydrous massage products, emulsions (by in the aqueous phase, suspensions, microemulsions, microcapsules, particles or ions (liposomes) and It is provided in the form of dispersing the oil phase in the ionic fragrance powder dispersion agent), or as a cream, epidermis, lotion, powder, ointment, spray or concealer stick. In addition, the cosmetic composition can be used in the form of a foam or aerosol composition (further containing a compressed propellant). These formulations can be obtained by methods generally known to those skilled in the art.

根據本揭露內容之一實施例,組成物可為防曬品。組成物之防曬係數(sun protection factor;SPF)可為10至50或更大,如根據以下式1計算。UVA之防護等級(PA)可為PA+至PA++++。According to an embodiment of the present disclosure, the composition may be a sunscreen product. The sun protection factor (SPF) of the composition can be 10 to 50 or greater, as calculated according to the following formula 1. The protection level (PA) of UVA can be from PA+ to PA++++.

[式1] 防曬係數=(在化妝品組成物塗抹至之皮膚部位處的最小紅斑劑量)/(在無化妝品組成物塗抹至之皮膚部位處的最小紅斑劑量)[Formula 1] Sun protection factor = (minimum erythema dose at the skin site where the cosmetic composition is applied)/(minimum erythema dose at the skin site where no cosmetic composition is applied)

根據本揭露內容之一實施例,取決於用途,組成物可進一步包含有機防曬劑或無機防曬劑。可包含基於組成物之總重量的0.01重量%至20重量%之量的有機防曬劑或無機防曬劑中的每一者,但不限於此。特定言之,有機防曬劑可包含辛基甲氧基肉桂酸酯、水楊酸辛酯、奧克立林(octocrylene)、丁基甲氧基二苯醯甲烷、氧苯酮、辛基三嗪酮、蒽醌酸甲酯、3,4-甲基亞苄基樟腦、對甲氧基肉桂酸異戊酯、雙-乙基己氧苯酚甲氧苯基三嗪、亞甲基雙苯并三唑四甲基丁基酚或類似者。此外,無機防曬劑可包含二氧化鈦、氧化鋅、氧化鐵或類似者之粉末。According to an embodiment of the present disclosure, depending on the application, the composition may further include an organic sunscreen agent or an inorganic sunscreen agent. Each of the organic sunscreen agent or the inorganic sunscreen agent may be included in an amount of 0.01% to 20% by weight based on the total weight of the composition, but is not limited thereto. In particular, organic sunscreens may include octyl methoxycinnamate, octyl salicylate, octocrylene, butylmethoxybenzophenone, oxybenzone, octyltriazinone, anthracene Methyl quinoneate, 3,4-methylbenzylidene camphor, isoamyl p-methoxycinnamate, bis-ethylhexyloxyphenol methoxyphenyl triazine, methylene bisbenzotriazole tetramethyl Butyl phenol or the like. In addition, the inorganic sunscreen agent may include powders of titanium dioxide, zinc oxide, iron oxide, or the like.

根據本揭露內容之一實施例,組成物可為化妝品產品。特定言之,組成物可經調配成飾底乳(makeup base)、粉底液、BB霜、CC霜、遮瑕膏、妝前底霜(makeup primer)或類似者,但不限於此。當將組成物塗抹至皮膚時,依靠微粒子之碗狀形狀,其展現至皮膚之優異服貼感。此外,由於組成物依靠此優異服貼感及皮脂控制能力,具有啞光且清爽之使用感覺,因此如與習知化妝品組成物相比,其可顯著減少細塵至皮膚之黏著。在此上下文中,根據本揭露內容之一實施例的組成物可用於防止細塵之黏著。According to an embodiment of the present disclosure, the composition may be a cosmetic product. Specifically, the composition can be formulated into makeup base, liquid foundation, BB cream, CC cream, concealer, makeup primer, or the like, but it is not limited thereto. When the composition is applied to the skin, relying on the bowl-like shape of the microparticles, it exhibits an excellent wearing feeling to the skin. In addition, since the composition has a matte and refreshing feeling of use due to its excellent wearing feeling and sebum control ability, it can significantly reduce the adhesion of fine dust to the skin compared with conventional cosmetic compositions. In this context, the composition according to an embodiment of the present disclosure can be used to prevent adhesion of fine dust.

根據本揭露內容之一實施例,化妝品組成物可包含活性成分連同其他成分,其限制性條件為,其他成分不會不利地影響主效應,或可提供與主效應之協同效應。取決於化妝品組成物之調配物或使用目的,根據本揭露內容的不同於活性成分之成分可由熟習此項技術者選擇及組合。除了以上提到之成分之外,若必要,根據本揭露內容之一實施例的化妝品組成物可進一步包含當前在化妝品組成物中使用之其他成分。舉例而言,此等成分包含保濕劑、潤膚劑、增稠劑、有機及無機顏料、有機粉末、防腐劑、殺菌劑、抗氧化劑、植物提取物、pH值改質劑、酒精、著色劑、香料、血流刺激劑、冷卻劑、防汗劑、純水或類似者。可併入至根據本揭露內容之化妝品組成物的此等成分不限於以上描述之成分。此外,可在不損及本揭露內容之目標及效應之情況下使用此等成分。 (實例)According to an embodiment of the present disclosure, the cosmetic composition may include active ingredients together with other ingredients, and the limitation is that the other ingredients will not adversely affect the main effect, or may provide a synergistic effect with the main effect. Depending on the formulation of the cosmetic composition or the purpose of use, ingredients other than the active ingredients according to the present disclosure can be selected and combined by those familiar with the art. In addition to the above-mentioned ingredients, if necessary, the cosmetic composition according to an embodiment of the present disclosure may further include other ingredients currently used in the cosmetic composition. For example, these ingredients include moisturizers, emollients, thickeners, organic and inorganic pigments, organic powders, preservatives, fungicides, antioxidants, plant extracts, pH modifiers, alcohol, colorants , Perfume, blood flow stimulant, cooling agent, antiperspirant, pure water or the like. The ingredients that can be incorporated into the cosmetic composition according to the present disclosure are not limited to the ingredients described above. In addition, these ingredients can be used without compromising the goals and effects of the content of this disclosure. (Example)

下文,將參考實例、比較實例及測試實例更詳細地解釋本揭露內容。以下實例及實驗僅是用於說明目的。此外,對熟習此項技術者將顯而易見的是,本揭露內容之範疇不限於以下實例、比較實例及測試實例。 [實例1]Hereinafter, the content of the disclosure will be explained in more detail with reference to examples, comparative examples and test examples. The following examples and experiments are for illustrative purposes only. In addition, it will be obvious to those familiar with the technology that the scope of the disclosure is not limited to the following examples, comparative examples, and test examples. [Example 1]

9 g聚乙烯醇經引入至反應容器,且溶解於2000 g蒸餾水中以製備水相。接下來,將200 g甲基丙烯酸甲酯(MMA)及25 g乙二醇二甲基丙烯酸酯引入至乳化劑且在其中攪拌達5分鐘,且接著將75 g雙-乙基己氧苯酚甲氧苯基三嗪(BEMT)進一步引入至其處且溶解達30分鐘以製備油相。接著,將3 g之2,2'-偶氮雙-(2,4-二甲基戊腈)作為引發劑引入,且在彼處混合。在此之後,將水相引入至乳化劑,且藉由使用此乳化劑進行分散聚合達30分鐘,且接著使混合物增溫以在50℃下進行反應,且反應達15小時。所得多分散之微粒子藉由使用減壓過濾器來脫水且用水洗滌三次,接著是真空乾燥。以此方式,獲得包含25重量%之雙-乙基己氧苯酚甲氧苯基三嗪之碗狀微粒子(良率= 90%,微粒子之平均直徑= 2 μm)。9 g of polyvinyl alcohol was introduced into the reaction vessel and dissolved in 2000 g of distilled water to prepare an aqueous phase. Next, 200 g of methyl methacrylate (MMA) and 25 g of ethylene glycol dimethacrylate were introduced into the emulsifier and stirred therein for 5 minutes, and then 75 g of bis-ethylhexoxyphenol methyl Oxyphenyltriazine (BEMT) was further introduced thereto and dissolved for 30 minutes to prepare an oil phase. Next, 3 g of 2,2'-azobis-(2,4-dimethylvaleronitrile) was introduced as an initiator, and mixed there. After that, the water phase was introduced to the emulsifier, and dispersion polymerization was performed by using this emulsifier for 30 minutes, and then the mixture was warmed to react at 50° C., and the reaction was performed for 15 hours. The resulting polydisperse microparticles were dehydrated by using a reduced pressure filter and washed with water three times, followed by vacuum drying. In this way, bowl-shaped particles containing 25% by weight of bis-ethylhexyloxyphenol methoxyphenyltriazine (yield rate = 90%, average particle diameter = 2 μm) were obtained.

第1A圖至第1F圖展示所得碗狀微粒子之掃描電子顯微鏡(scanning electron microscopic;SEM)影像(第1A圖及第1B圖),連同比較實例之SEM影像,亦即,多孔PMMA球形粒子(比較實例1,第1C圖及第1D圖)及無孔PMMA球形粒子(比較實例2,第1E圖及第1F圖)。右側影像(第1B圖、第1D圖、第1F圖)中之各者為如與對應的左側影像(第1A圖、第1C圖、第1E圖)相比在較高放大率下拍攝之影像,且圖示同一樣本。如可自第1A圖及第1B圖看出,根據本揭露內容之一實施例的微粒子具有特性圓碗狀結構。認為,此形狀自形成經組態以在其中穩定地並有高含量之雙-乙基己氧苯酚甲氧苯基三嗪之粒子的聚合物基質之高交聯程度及均質地併入於聚合物基質中的雙-乙基己氧苯酚甲氧苯基三嗪之濃度產生。Figures 1A to 1F show the scanning electron microscopic (SEM) images (Figures 1A and 1B) of the bowl-shaped particles obtained, together with the SEM images of the comparative example, that is, porous PMMA spherical particles (comparison Example 1, Figure 1C and Figure 1D) and non-porous PMMA spherical particles (Comparative Example 2, Figure 1E and Figure 1F). Each of the images on the right (Figure 1B, Figure 1D, Figure 1F) is an image taken at a higher magnification as compared with the corresponding left image (Figure 1A, Figure 1C, Figure 1E) , And the same sample is shown. As can be seen from FIG. 1A and FIG. 1B, the microparticles according to an embodiment of the present disclosure have a characteristic round bowl-shaped structure. It is believed that this shape is formed from the high degree of cross-linking and homogeneous integration of the polymer matrix configured to stably incorporate therein a high content of bis-ethylhexoxyphenol methoxyphenyl triazine particles in the polymer matrix. The concentration of bis-ethylhexyloxyphenol methoxyphenyl triazine in the substance matrix is produced.

此外,所得碗狀微粒子用以判定油吸收性及總浸入量。根據0JIS K 5101-13-1,將油吸收性判定為針對基體在控制於室溫(23℃)下之房間中之油吸收性之測試方法,且藉由使用孔隙率計(Autopore IV 9500,micrometrics,Londonderry,NH,USA)來判定總浸入量。油吸收性之結果與總浸入量之結果相互相關。如可自以下表1之結果看出,根據本揭露內容之一實施例的微粒子具有0.888 mL/g之油吸收性,及1.37 mL/g之總浸入量。結果對應於比無孔PMMA球形粒子之油吸收性高至少150%之油吸收性,且對應於比無孔PMMA球形粒子之總浸入量高至少210%之總浸入量。此外,結果對應於多孔PMMA球形粒子之油吸收性之約56%之油吸收性,且對應於多孔PMMA球形粒子之總浸入量之約0.87倍之總浸入量。此是自根據本揭露內容之一實施例的微粒子之碗狀形狀及其無孔特性得出。 [表1]   油吸收性 (mL/g) 總浸入量 (mL/g) 實例1 (碗狀無孔微粒子) 0.888 1.37 比較實例1 (多孔球形PMMA微粒子) 1.60 1.57 比較實例2 (無孔球形PMMA微粒子) 0.573 0.65 [測試實例1]In addition, the obtained bowl-shaped particles were used to determine oil absorption and total immersion. According to 0JIS K 5101-13-1, the oil absorption is judged as a test method for the oil absorption of the substrate in a room controlled at room temperature (23°C), and by using a porosity meter (Autopore IV 9500, micrometrics, Londonderry, NH, USA) to determine the total immersion. The results of oil absorption are correlated with the results of total immersion. As can be seen from the results in Table 1 below, the microparticles according to one embodiment of the present disclosure have an oil absorbency of 0.888 mL/g and a total immersion amount of 1.37 mL/g. The result corresponds to an oil absorption that is at least 150% higher than that of the non-porous PMMA spherical particles, and corresponds to a total immersion that is at least 210% higher than that of the non-porous PMMA spherical particles. In addition, the result corresponds to an oil absorption of about 56% of the oil absorption of the porous PMMA spherical particles, and corresponds to a total immersion of about 0.87 times the total immersion of the porous PMMA spherical particles. This is derived from the bowl-shaped shape and non-porous characteristics of the particles according to an embodiment of the present disclosure. [Table 1] Oil absorption (mL/g) Total immersion (mL/g) Example 1 (bowl-shaped non-porous particles) 0.888 1.37 Comparative Example 1 (Porous spherical PMMA particles) 1.60 1.57 Comparative Example 2 (Non-porous spherical PMMA particles) 0.573 0.65 [Test Case 1]

為了就使用感覺來分析根據本揭露內容之一實施例的包含碗狀微粒子之組成物,與使用對應於微粒子之不同類型之粉末的比較實例相比,來進行以下測試。In order to analyze the composition containing bowl-shaped microparticles according to an embodiment of the present disclosure in terms of the feeling of use, the following test was performed compared with a comparative example using different types of powders corresponding to the microparticles.

首先,藉由使用在表2中展示之組成物來混合油相成分,跟著為均質分散及溶解。在增溫至40℃至50℃下溶解水相成分,且藉由使用均質機,引入至油相成分以獲得W/S型化妝品組成物中之每一者。 [表2]   成分 實例2 比較實例3 (載劑) 比較實例4 (CR50) 比較實例5 (Art-pearl) 油相 乙基已基甲氧基肉桂酸酯 5 5 5 5 水楊酸乙基己酯 3 3 3 3 二甲基矽氧烷 20 20 20 20 環五矽氧烷*環六矽氧烷 10 10 10 10 C12-15烷基苯甲酸酯*C12-15乙醇 6 6 6 6 二硬脂基二甲基胺鋰皂石 0.3 0.3 0.3 0.3 PEG-10二甲基矽氧烷 1.5 1.5 1.5 1.5 生育酚*月桂基PEG-9聚二甲基矽氧乙基二甲基矽氧烷 1.5 1.5 1.5 1.5 實例1 8 - - - 比較實例2 - - - 8 二氧化鈦(CI 77891)*氫氧化鋁*三乙氧基辛醯基矽烷     8   水相 蒸餾水 至100 至100 至100 至100 多元醇 5 5 5 5 氯化鈉 1 1 1 1 2Na EDTA 0.05 0.05 0.05 0.05 防腐劑 1.15 1.15 1.15 1.15 共計 (重量%)   100 100 100 100 First, the oil phase ingredients are mixed by using the composition shown in Table 2, followed by homogeneous dispersion and dissolution. The water phase ingredients are dissolved at a temperature of 40°C to 50°C, and introduced into the oil phase ingredients by using a homogenizer to obtain each of the W/S-type cosmetic compositions. [Table 2] ingredient Example 2 Comparative Example 3 (Carrier) Comparative Example 4 (CR50) Comparative Example 5 (Art-pearl) Oil phase Ethylhexyl methoxycinnamate 5 5 5 5 Ethylhexyl salicylate 3 3 3 3 Dimethylsiloxane 20 20 20 20 Cyclopentasiloxane*Cyclohexasiloxane 10 10 10 10 C12-15 Alkyl Benzoate*C12-15 Ethanol 6 6 6 6 Distearyl dimethylamine hectorite 0.3 0.3 0.3 0.3 PEG-10 Dimethylsiloxane 1.5 1.5 1.5 1.5 Tocopherol*Lauryl PEG-9 Polydimethylsiloxane Ethyl Dimethicone 1.5 1.5 1.5 1.5 Example 1 8 - - - Comparative example 2 - - - 8 Titanium Dioxide (CI 77891)*Aluminum Hydroxide*Triethoxyoctylsilane 8 water box Distilled water Up to 100 Up to 100 Up to 100 Up to 100 Polyol 5 5 5 5 Sodium chloride 1 1 1 1 2Na EDTA 0.05 0.05 0.05 0.05 preservative 1.15 1.15 1.15 1.15 Total (weight%) 100 100 100 100

實例2為包含根據實例1之微粒子粉末之調配物,比較實例3為不包含粉末之載劑調配物,比較實例4為包含可作為OTS-2 TiO2 CR-50得到之TiO2 著色劑之原材料之調配物,且比較實例5為包含比較實例2(無孔球形PMMA微粒子)之調配物。Example 2 is a formulation containing the fine particle powder according to Example 1, Comparative Example 3 is a carrier formulation that does not contain powder, and Comparative Example 4 is a raw material containing a TiO 2 colorant that can be obtained as OTS-2 TiO 2 CR-50 The formulation of Comparative Example 5 is a formulation containing Comparative Example 2 (non-porous spherical PMMA particles).

接著,允許Amore Pacific研究實驗室中之10個培養面板(AP R&D皮膚護理培養面板)使用根據實例2及比較實例2至4的調配物中之每一者,及評估根據以下方案之使用感覺。 - 評估在塗抹後且吸收後之品質,同時允許測試產品經由滾動達2分鐘吸收至皮膚。 - 針對同一測試產品重複評估兩次。 1) 將同一乳液按預定量塗抹至前臂,且接著允許停住達3分鐘,以用於吸收。 2) 在吸收後,使用同一泡沫清潔劑來清潔前臂。 3) 藉由使用具有5 cm之直徑的圓戳在清潔完成之前臂處標記塗抹部位。 4) 按50 μL之量在標記之圓圈中提供測試產品。 5) 藉由使用食指在10秒內進行滾動兩次(兩次/秒)。 6) 在滾動後,判定吸收率(程度),同時用食指及中指輕拍皮膚。 7) 在完成吸收後,允許測試部位停住,直至2分鐘鬧鈴響起。 8) 在2分鐘後,評估吸收後品質。Next, allow 10 culture panels (AP R&D skin care culture panels) in the Amore Pacific research laboratory to use each of the formulations according to Example 2 and Comparative Examples 2 to 4, and evaluate the feeling of use according to the following scheme. -Evaluate the quality after application and absorption, while allowing the test product to be absorbed into the skin by rolling for 2 minutes. -Repeat the evaluation twice for the same test product. 1) Apply the same lotion to the forearm in a predetermined amount, and then allow to stop for 3 minutes for absorption. 2) After absorption, use the same foam cleaner to clean the forearm. 3) Mark the application area on the arm before cleaning is completed by using a round stamp with a diameter of 5 cm. 4) Provide the test product in the marked circle in the amount of 50 μL. 5) Use the index finger to scroll twice within 10 seconds (twice/sec). 6) After rolling, determine the absorption rate (degree), and pat the skin with your index finger and middle finger at the same time. 7) After the absorption is complete, allow the test site to stop until the alarm sounds for 2 minutes. 8) After 2 minutes, evaluate the quality after absorption.

測試項包含對應於在每一組成物之塗抹後之使用感覺的10個項(涼度、可塗抹性、滑爽性、油膩感、油滑感、水感、厚重感、服貼感、黏性及吸收速率)及對應於在吸收後之使用感覺的7個項(光澤、在吸收後之油滑感、滋潤感、在吸收後之黏性、柔軟度、柔滑性及殘留感)。The test items include 10 items (coolness, spreadability, smoothness, greasy feel, greasy feel, watery feel, heaviness, stickiness, stickiness) corresponding to the feeling of use after application of each composition And absorption rate) and 7 items corresponding to the feeling of use after absorption (gloss, greasy feeling after absorption, moisturizing feeling, stickiness after absorption, softness, smoothness and residual feeling).

結果,如在第2圖中展示,測試產品大體展示類似的可塗抹性趨勢,但取決於粉末類型,存在極小差異。在比較實例4(CR50)之情況中,歸因於其獨特之黏稠可塗抹性及厚重使用感覺,其展現厚重的可塗抹性,且特定言之,傾向於難以吸收,此是由於調配物未被吸收,而是保留於皮膚上。As a result, as shown in Figure 2, the test product generally exhibits a similar spreadability trend, but depending on the powder type, there is a very small difference. In the case of Comparative Example 4 (CR50), due to its unique stickiness and spreadability and heavy use feel, it exhibits heavy spreadability and, in particular, tends to be difficult to absorb. This is due to the fact that the formulation does not It is absorbed but remains on the skin.

如在第3圖中展示,實例2及比較實例5(Art-pearl)展現在吸收後之類似趨勢,但取決於粉末類型,存在完成感差異。在比較實例3(載劑)之情況中,其展現在吸收後之強油滑感,且經評估提供留下高光澤及殘留之使用感覺。在實例2之情況中,其展現如與比較實例5(Art-pearl)相比類似的完成感趨勢,且提供在吸收後之較低光澤及油滑感。在比較實例5(Art-pearl)之情況中,評估如與實例2相比較柔軟且較柔滑之感覺(依靠其自粉末顆粒得出之感覺),但展現在吸收後如與實例2相比的較高油滑感及光澤。As shown in Figure 3, Example 2 and Comparative Example 5 (Art-pearl) show similar trends after absorption, but depending on the powder type, there is a difference in sense of completion. In the case of Comparative Example 3 (vehicle), it exhibited a strong greasy feel after absorption, and was evaluated to provide a feeling of use that left high gloss and residue. In the case of Example 2, it exhibited a trend of finishing feeling similar to that of Comparative Example 5 (Art-pearl), and provided lower gloss and oily feeling after absorption. In the case of Comparative Example 5 (Art-pearl), the evaluation is as soft and smoother as that of Example 2 (depending on the feeling derived from the powder particles), but it is shown after absorption as compared with Example 2 High oiliness and luster.

第4圖及第5圖展示就使用感覺而言的實例2及比較實例3(載劑)之詳細評估結果。如在第5圖中展示,實例2展示如與比較實例3(載劑)相比,在吸收後較柔軟之使用感覺,且提供在吸收後顯著減少之油滑感、殘留感及黏性。認為,根據實例2之碗狀微粒子吸收皮膚皮脂以提供更清爽之使用感覺。 [測試實例2]Figures 4 and 5 show detailed evaluation results of Example 2 and Comparative Example 3 (vehicle) in terms of feeling of use. As shown in Figure 5, Example 2 shows a softer feel after absorption as compared to Comparative Example 3 (vehicle), and provides a significantly reduced oily feel, residual feel and stickiness after absorption. It is believed that the bowl-shaped microparticles according to Example 2 absorb skin sebum to provide a more refreshing feeling of use. [Test Case 2]

進行以下臨床測試以評估根據本揭露內容之一實施例的包含碗狀微粒子之組成物(實例2,產品名稱:3088008)之細塵防護能力。The following clinical tests were performed to evaluate the fine dust protection ability of the bowl-shaped microparticle-containing composition (Example 2, product name: 30880008) according to an embodiment of the present disclosure.

以下描述為自研究報告(PNK-18N15-BR1R2)「針對3088008(CSR-B1W-43396)之膚色、辨認之美白指數(VB)、均質性、皮膚紋理覆蓋能力、水損失及代用品細塵防護能力之人體塗抹測試」提取之測試結果,此報告由Amore Pacific公司向皮膚臨床研究中心請求且在2018年12月26日接收到。The following description is a self-research report (PNK-18N15-BR1R2) "For 30880008 (CSR-B1W-43396) skin tone, recognized whitening index (VB), homogeneity, skin texture coverage, water loss, and substitute fine dust protection The test results extracted from the Human Smear Test of Ability. This report was requested by Amore Pacific from the Skin Clinical Research Center and received on December 26, 2018.

測試產品 產品名稱:3088008,材料參考編號:18N15-BR1-S2Test product Product name: 30880008, material reference number: 18N15-BR1-S2

測試產品之使用 在於測試主體之前臂處定義了測試產品塗抹部位及人工皮脂塗抹部位(寬度×長度=1.5×4 cm)後,按1 μL/cm2 之量將測試產品及人工皮脂塗抹至定義之部位。Using the test products in that the forearm of the test body of the defined test product application site and the artificial sebum application area (width × length = 1.5 × 4 cm), press 1 μL / quantity cm 2 of the test products and the artificial sebum smear to define Of the site.

使用測試產品之次數 一次Number of times the test product is used once

測試主體之選擇 25歲至35歲女性符合選擇準則,且不對應於排斥準則。 - 選擇準則 1. 接收待由測試經理通告的關於專案之充分解釋之人員,或接收來自測試經理之信任且在同意表單中書寫及簽名之人員。 2. 無包含皮膚病之急性及慢性身體疾病之健康人員。 3. 允許在測試期間追蹤觀察之人員。 - 排除準則 1. 患有精神病之人員。 2. 患有傳染性皮膚病之人員。 3. 在開始測試前之3個月內接收免疫抑制藥物治療之人員。 4. 在開始測試前之一個月內接收全身類固醇或光治療之人員。 5. 在測試部位處具有傷口且使得難以測試之人員。 6. 具有遺傳性過敏皮膚之人員。 7. 對化妝品、藥物或日常光曝露顯著敏感或具有過敏症之人員。 8. 在開始測試前之3個月內接收皮膚去角質或皮膚護理之人員。 9. 孕婦或哺乳期婦女。 10. 由測試經理或負責測試之人員判斷為不適合於人體塗抹測試之其他人員。Choice of test subject Women aged 25 to 35 meet the selection criteria and do not correspond to the exclusion criteria. -Selection criteria 1. Accept the person who will be notified by the test manager who fully explains the project, or accept the person who is trusted by the test manager and writes and signs in the consent form. 2. There are no healthy persons with acute or chronic physical diseases including skin diseases. 3. Personnel who are allowed to follow up during the test. -Exclusion criteria 1. People suffering from mental illness. 2. People with infectious skin diseases. 3. Those who received immunosuppressive drug treatment within 3 months before the start of the test. 4. Those who received systemic steroids or light therapy within one month before the start of the test. 5. Those who have wounds at the test site that make it difficult to test. 6. People with allergic skin. 7. Persons who are significantly sensitive or allergic to cosmetics, drugs or daily light exposure. 8. Persons who received skin exfoliation or skin care within 3 months before the start of the test. 9. Pregnant or breastfeeding women. 10. Other personnel judged by the test manager or the person in charge of the test as unsuitable for the human smear test.

測試方法 為了進行有幫助之評估,允許測試主體在處於20℃至25℃之溫度、40%至60%之濕度之恒溫/恒濕條件下之房間中休息30分鐘,使得其皮膚表面溫度及濕度可適應測試空間之環境。在休息時,限制測試主體水攝入。為了進行客觀判定,一個研究員進行測試,且每次測試時測試同一部位。testing method For helpful evaluation, allow the test subject to rest for 30 minutes in a room at a temperature of 20°C to 25°C and a humidity of 40% to 60% in a constant temperature/constant humidity condition, so that the skin surface temperature and humidity can be adapted The environment of the test space. During rest, limit the water intake of the test subject. In order to make an objective judgment, a researcher conducts the test and tests the same part each time.

在使用測試產品前、在使用測試產品後及在施加了代用品細塵後,判定代用品細塵防護能力。Before using the test product, after using the test product and after applying the substitute fine dust, determine the substitute fine dust protection ability.

為了判定代用品細塵防護效果,在測試主體之前臂處定義測試產品塗抹部位及人工皮脂塗抹部位(寬度×長度1.5×4 cm),且接著將測試產品及人工皮脂塗抹至其處。接著,將主體之前臂部位轉移至噴灑機中之密封空間,且在所有方向上噴灑包含碳作為代用品細塵之主要成分的足夠量(約1.5 g)之代用品細塵(碳粉末)以引起吸附。在使用測試產品前、在使用測試產品後及在噴灑了代用品細塵後,藉由使用Visia-CR來對前臂部位拍照。拍照之影像由mage-pro® plus分析,且在此等影像中標明一具體區域以按區域中之亮度(強度)之差進行評估。隨著區域接近黑色,亮度(強度)降低。每一亮度(強度)值是藉由自色域(0至255)之最大值255將其減去來校正。In order to determine the fine dust protection effect of the substitute, define the test product application site and artificial sebum application site (width x length 1.5 x 4 cm) on the arm of the test subject, and then apply the test product and artificial sebum to them. Then, transfer the front arm part of the main body to the sealed space in the sprayer, and spray sufficient amount (about 1.5 g) of the substitute fine dust (carbon powder) containing carbon as the main component of the substitute fine dust in all directions To cause adsorption. Before using the test product, after using the test product, and after spraying the substitute fine dust, use Visia-CR to take pictures of the forearm. The photographed images are analyzed by mage-pro ® plus, and a specific area is marked in these images for evaluation based on the difference in brightness (intensity) in the area. As the area approaches black, the brightness (intensity) decreases. Each brightness (intensity) value is corrected by subtracting it from the maximum value 255 of the color gamut (0 to 255).

代用品細塵防護能力之判定之結果 在使用測試產品後判定測試產品之代用品細塵防護能力之改變。 -  測試產品:如與在使用測試產品後相比,在噴灑了代用品細塵後,存在29.377%之顯著增大(p < 0.05)。 -  人工皮脂:如與在使用測試產品後相比,在噴灑了代用品細塵後,存在32.436%之顯著增大(p < 0.05)。 -  群組間比較:如與人工皮脂相比,基於使用測試產品後之結果,在噴灑代用品細塵後,測試產品展示顯著差異(p < 0.05)(見第6圖至第8圖)。The result of the judgment of the fine dust protection ability of the substitute After using the test product, determine the change in the fine dust protection ability of the test product substitute. -Test product: Compared with the test product, after spraying the substitute fine dust, there is a significant increase of 29.377% (p <0.05). -Artificial sebum: If compared with the test product, after spraying the substitute fine dust, there is a significant increase of 32.436% (p <0.05). -Comparison between groups: If compared with artificial sebum, based on the results after using the test product, after spraying the fine dust substitute, the test product showed a significant difference (p <0.05) (see Figure 6 to Figure 8).

結論 因此,判斷「3088008」產品為幫助改良在一次使用之情況下的代用品細塵防護能力之產品。in conclusion Therefore, it is judged that the "3088008" product is a product that helps to improve the fine dust protection ability of substitutes in one-time use.

根據本揭露內容,可提供以下實施例。According to the present disclosure, the following embodiments can be provided.

根據第一實施例,提供包含雙-乙基己氧苯酚甲氧苯基三嗪分散於其中之聚合物基質的碗狀無孔微粒子用於製備用於改良防曬品之皮脂控制能力之組成物之用途。According to the first embodiment, a bowl-shaped non-porous microparticle containing a polymer matrix in which bis-ethylhexyloxyphenol methoxyphenyl triazine is dispersed is provided for preparing a composition for improving the sebum control ability of sunscreens use.

根據第二實施例,提供如在第一實施例中定義之用途,其中包含基於微粒子之總重量的20重量%至30重量%之量的雙-乙基己氧苯酚甲氧苯基三嗪。According to the second embodiment, there is provided the use as defined in the first embodiment, which contains bis-ethylhexyloxyphenol methoxyphenyltriazine in an amount of 20% to 30% by weight based on the total weight of the microparticles.

根據第三實施例,提供如在第一或第二實施例中定義之用途,其中此等微粒子之平均直徑為1 μm至10 μm。According to the third embodiment, there is provided the use as defined in the first or second embodiment, wherein the average diameter of these fine particles is 1 μm to 10 μm.

根據第四實施例,提供如在第一至第三實施例中任一項中定義之用途,其中此等微粒子之皮脂吸收性為0.5 mL/g至1 mL/g。According to the fourth embodiment, the use as defined in any one of the first to third embodiments is provided, wherein the sebum absorbability of these microparticles is 0.5 mL/g to 1 mL/g.

根據第五實施例,提供如在第一至第四實施例中任一項中定義之用途,其中此等微粒子之皮脂浸入量為1.0 mL/g至1.5 mL/g。According to the fifth embodiment, the use as defined in any one of the first to fourth embodiments is provided, wherein the sebum infiltration amount of these fine particles is 1.0 mL/g to 1.5 mL/g.

根據第六實施例,提供如在第一至第五實施例中任一項中定義之用途,其中聚合基質包含雙-乙基己氧苯酚甲氧苯基三嗪,及可聚合單體與多官能交聯劑之聚合產物。According to a sixth embodiment, there is provided the use as defined in any one of the first to fifth embodiments, wherein the polymer matrix comprises bis-ethylhexyloxyphenol methoxyphenyl triazine, and polymerizable monomers and poly Polymerization product of functional crosslinking agent.

根據第七實施例,提供如在第一至第六實施例中任一項中定義之用途,其中可聚合單體包含選自由以下各者組成之群組的至少一者:選自由苯乙烯、甲基苯乙烯、乙基苯乙烯、氟苯乙烯、氯苯乙烯及乙烯基甲苯組成之群組的至少一種芳族乙烯基單體;及選自由甲基(甲基)丙烯酸酯、乙基(甲基)丙烯酸酯、丁基(甲基)丙烯酸酯、辛基(甲基)丙烯酸酯、硬脂醯(甲基)丙烯酸酯、苯甲基(甲基)丙烯酸酯及縮水甘油基(甲基)丙烯酸酯組成之群組的至少一種丙烯酸乙烯基單體。According to a seventh embodiment, there is provided the use as defined in any one of the first to sixth embodiments, wherein the polymerizable monomer includes at least one selected from the group consisting of: styrene, At least one aromatic vinyl monomer in the group consisting of methyl styrene, ethyl styrene, fluorostyrene, chlorostyrene and vinyl toluene; and selected from methyl (meth) acrylate, ethyl ( Meth) acrylate, butyl (meth) acrylate, octyl (meth) acrylate, stearyl (meth) acrylate, benzyl (meth) acrylate and glycidyl (meth) acrylate ) At least one acrylic vinyl monomer from the group consisting of acrylic esters.

根據第八實施例,提供如在第一至第七實施例中任一項中定義之用途,其中多官能交聯劑包含選自由以下各者組成之群組的至少一者:二乙烯基苯、乙二醇二甲基丙烯酸酯、二乙二醇二甲基丙烯酸酯、三乙二醇二甲基丙烯酸酯、三甲基丙烷三甲基丙烯酸酯、1,3-丁二醇二甲基丙烯酸酯、1,6-己二醇二甲基丙烯酸酯及三(甲基)丙烯酸酯。According to an eighth embodiment, there is provided the use as defined in any one of the first to seventh embodiments, wherein the multifunctional crosslinking agent includes at least one selected from the group consisting of: divinylbenzene , Ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, trimethylpropane trimethacrylate, 1,3-butanediol dimethyl Acrylate, 1,6-hexanediol dimethacrylate and tri(meth)acrylate.

根據第九實施例,提供如在第一至第八實施例中任一項中定義之用途,其中組成物包含基於組成物之總重量的1重量%至50重量%之量的微粒子。According to a ninth embodiment, there is provided the use as defined in any one of the first to eighth embodiments, wherein the composition includes fine particles in an amount of 1% to 50% by weight based on the total weight of the composition.

根據第十實施例,提供如在第一至第九實施例中任一項中定義之用途,其中組成物為油包水(W/O)型組成物。According to a tenth embodiment, there is provided the use as defined in any one of the first to ninth embodiments, wherein the composition is a water-in-oil (W/O) type composition.

根據第十一實施例,提供如在第一至第十實施例中任一項中定義之用途,其中組成物為化妝品產品。According to an eleventh embodiment, there is provided the use as defined in any one of the first to tenth embodiments, wherein the composition is a cosmetic product.

根據第十二實施例,提供如在第一至第十一實施例中任一項中定義之用途,其中組成物用於在防止細塵吸附中使用。According to the twelfth embodiment, there is provided the use as defined in any one of the first to eleventh embodiments, wherein the composition is used for preventing the adsorption of fine dust.

no

第1A圖為圖示根據本發明之一實施例的碗狀微粒子之照片影像。FIG. 1A is a photographic image of bowl-shaped particles according to an embodiment of the present invention.

第1B圖為如在高放大率下拍攝的第1A圖之碗狀微粒子之照片影像。Figure 1B is a photo of the bowl-shaped particles in Figure 1A taken under high magnification.

第1C圖為圖示作為本揭露內容之一比較實例的多孔球形聚甲基丙烯酸甲酯(PMMA)之照片影像。Figure 1C shows a photograph of a porous spherical polymethyl methacrylate (PMMA) as a comparative example of the present disclosure.

第1D圖為如在高放大率下拍攝的第1C圖之多孔球形PMMA粒子之照片影像。Figure 1D is a photo image of porous spherical PMMA particles in Figure 1C taken under high magnification.

第1E圖為圖示作為本揭露內容之一比較實例的無孔球形PMMA粒子之照片影像。Fig. 1E is a photograph showing a non-porous spherical PMMA particle as a comparative example of the present disclosure.

第1F圖為如在高放大率下拍攝的第1E圖之無孔球形PMMA粒子之照片影像。Figure 1F is a photo of the non-porous spherical PMMA particles in Figure 1E taken under high magnification.

第2圖展示在根據本揭露內容之一實施例的包含碗狀微粒子之組成物及包含不同類型之粉末之組成物塗抹至皮膚後的使用感覺之評估之結果。Figure 2 shows the results of the evaluation of the feeling of use of the composition containing bowl-shaped particles and the composition containing different types of powders after being applied to the skin according to an embodiment of the present disclosure.

第3圖展示在根據本揭露內容之一實施例的包含碗狀微粒子之組成物及包含不同類型之粉末之組成物塗抹且吸收至皮膚後的使用感覺之評估之結果。Figure 3 shows the results of the evaluation of the feeling of use of the composition containing bowl-shaped particles and the composition containing different types of powders after being applied and absorbed into the skin according to an embodiment of the present disclosure.

第4圖展示在根據本揭露內容之一實施例的包含碗狀微粒子之組成物及包含不同類型之粉末之組成物塗抹至皮膚後的使用感覺之更詳細評估之結果。Figure 4 shows the results of a more detailed evaluation of the feeling of use of the composition containing bowl-shaped particles and the composition containing different types of powders after being applied to the skin according to an embodiment of the present disclosure.

第5圖展示在根據本揭露內容之一實施例的包含碗狀微粒子之組成物及包含不同類型之粉末之組成物塗抹且吸收至皮膚後的使用感覺之更詳細評估之結果。Figure 5 shows the results of a more detailed evaluation of the feeling of use of a composition containing bowl-shaped particles and a composition containing different types of powders after being applied and absorbed into the skin according to an embodiment of the present disclosure.

第6圖圖示根據本揭露內容之一實施例的包含碗狀微粒子之組成物之細塵防護能力之判定結果。FIG. 6 illustrates the result of determining the fine dust protection ability of a composition containing bowl-shaped particles according to an embodiment of the present disclosure.

第7圖圖示根據本揭露內容之一實施例的包含碗狀微粒子之組成物與在使用此組成物前相比的細塵防護能力之判定結果。FIG. 7 illustrates the result of judging the fine dust protection ability of a composition containing bowl-shaped particles according to an embodiment of the present disclosure as compared with before using the composition.

第8圖圖示根據本揭露內容之一實施例的包含碗狀微粒子之組成物與在使用此組成物後相比的細塵防護能力之判定結果。FIG. 8 illustrates the result of judging the fine dust protection ability of a composition containing bowl-shaped particles according to an embodiment of the present disclosure compared with the composition after using the composition.

國內寄存資訊(請依寄存機構、日期、號碼順序註記) 無 國外寄存資訊(請依寄存國家、機構、日期、號碼順序註記) 無Domestic deposit information (please note in the order of deposit institution, date and number) no Foreign hosting information (please note in the order of hosting country, institution, date, and number) no

Claims (12)

一種包含雙-乙基己氧苯酚甲氧苯基三嗪分散於其中之聚合物基質的碗狀無孔微粒子用於製備一用於改良一防曬品之一皮脂控制能力之組成物之用途。A bowl-shaped non-porous microparticle containing a polymer matrix in which bis-ethylhexyloxyphenol methoxyphenyl triazine is dispersed is used to prepare a composition for improving the sebum control ability of a sunscreen product. 如請求項1所述之用途,其中包含基於微粒子之總重量的20重量%至30重量%之量的該雙-乙基己氧苯酚甲氧苯基三嗪。The use according to claim 1, wherein the bis-ethylhexyloxyphenol methoxyphenyl triazine is contained in an amount of 20% to 30% by weight based on the total weight of the fine particles. 如請求項1所述之用途,其中該等微粒子之平均直徑為1 μm至10 μm。The use according to claim 1, wherein the average diameter of the fine particles is 1 μm to 10 μm. 如請求項1所述之用途,其中該等微粒子之皮脂吸收性為0.5 mL/g至1 mL/g。The use according to claim 1, wherein the sebum absorbability of the fine particles is 0.5 mL/g to 1 mL/g. 如請求項1所述之用途,其中該等微粒子之皮脂浸入量為1.0 mL/g至1.5 mL/g。The use according to claim 1, wherein the sebum soaking amount of the fine particles is 1.0 mL/g to 1.5 mL/g. 如請求項1所述之用途,其中該聚合物基質包含雙-乙基己氧苯酚甲氧苯基三嗪,及可聚合單體與一多官能交聯劑之聚合產物。The use according to claim 1, wherein the polymer matrix comprises bis-ethylhexyloxyphenol methoxyphenyltriazine, and a polymerization product of a polymerizable monomer and a multifunctional crosslinking agent. 如請求項6所述之用途,其中該可聚合單體包含選自由以下各者組成之群組的至少一者:選自由苯乙烯、甲基苯乙烯、乙基苯乙烯、氟苯乙烯、氯苯乙烯及乙烯基甲苯組成之群組的至少一種芳族乙烯基單體;及選自由甲基(甲基)丙烯酸酯、乙基(甲基)丙烯酸酯、丁基(甲基)丙烯酸酯、辛基(甲基)丙烯酸酯、硬脂醯(甲基)丙烯酸酯、苯甲基(甲基)丙烯酸酯及縮水甘油基(甲基)丙烯酸酯組成之群組的至少一種丙烯酸乙烯基單體。The use according to claim 6, wherein the polymerizable monomer comprises at least one selected from the group consisting of: styrene, methylstyrene, ethylstyrene, fluorostyrene, chlorine At least one aromatic vinyl monomer in the group consisting of styrene and vinyl toluene; and selected from methyl (meth)acrylate, ethyl (meth)acrylate, butyl (meth)acrylate, At least one acrylic vinyl monomer from the group consisting of octyl (meth)acrylate, stearyl (meth)acrylate, benzyl (meth)acrylate, and glycidyl (meth)acrylate . 如請求項6所述之用途,其中該多官能交聯劑包含選自由以下各者組成之群組的至少一者:二乙烯基苯、乙二醇二甲基丙烯酸酯、二乙二醇二甲基丙烯酸酯、三乙二醇二甲基丙烯酸酯、三甲基丙烷三甲基丙烯酸酯、1,3-丁二醇二甲基丙烯酸酯、1,6-己二醇二甲基丙烯酸酯及三(甲基)丙烯酸酯。The use according to claim 6, wherein the multifunctional crosslinking agent comprises at least one selected from the group consisting of: divinylbenzene, ethylene glycol dimethacrylate, diethylene glycol dimethacrylate Methacrylate, triethylene glycol dimethacrylate, trimethylpropane trimethacrylate, 1,3-butanediol dimethacrylate, 1,6-hexanediol dimethacrylate And tri(meth)acrylate. 如請求項1所述之用途,其中該組成物包含基於該組成物之總重量的1重量%至50重量%之量的該等微粒子。The use according to claim 1, wherein the composition contains the fine particles in an amount of 1% to 50% by weight based on the total weight of the composition. 如請求項1所述之用途,其中該組成物為一油包水(W/O)型組成物。The use according to claim 1, wherein the composition is a water-in-oil (W/O) type composition. 如請求項1所述之用途,其中該組成物為一化妝品產品。The use according to claim 1, wherein the composition is a cosmetic product. 如請求項1所述之用途,其中該組成物用於在防止細塵吸附中使用。The use according to claim 1, wherein the composition is used to prevent the adsorption of fine dust.
TW109114991A 2019-05-15 2020-05-06 Sunscreen cosmetic composition having sebum absorbing ability TW202108116A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190057114A KR20200132142A (en) 2019-05-15 2019-05-15 Sun screen cosmetic composition for having sebum absorbing ability
KR10-2019-0057114 2019-05-15

Publications (1)

Publication Number Publication Date
TW202108116A true TW202108116A (en) 2021-03-01

Family

ID=73290239

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109114991A TW202108116A (en) 2019-05-15 2020-05-06 Sunscreen cosmetic composition having sebum absorbing ability

Country Status (4)

Country Link
KR (1) KR20200132142A (en)
SG (1) SG11202110332WA (en)
TW (1) TW202108116A (en)
WO (1) WO2020231036A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023054803A1 (en) * 2021-09-29 2023-04-06 코스맥스 주식회사 Oil dispersion-type solid cosmetic composition comprising polymer powder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2867676B1 (en) * 2004-03-22 2006-06-02 Oreal COSMETIC COMPOSITION COMPRISING CONCAVED PARTICLES
FR2902648B1 (en) * 2006-06-22 2018-05-18 L'oreal AQUEOUS PHOTOPROTECTIVE COMPOSITION CONTAINING PAINTED OR ANNULAR PARTICLES OF SILICONE MATERIAL AND AT LEAST ONE UV FILTER
KR101543019B1 (en) 2008-11-07 2015-08-10 (주)아모레퍼시픽 Cosmetic composition for removal of sebum containing metal hydroxide
KR101833612B1 (en) * 2016-03-30 2018-02-28 선진뷰티사이언스(주) Polymer composite particles containing much of organic sunscreen agents and the method for preparing thereof
KR20180063664A (en) * 2016-12-02 2018-06-12 코오롱생명과학 주식회사 Hemi-sphere polymer bead containing uv absorbers and the method for preparing thereof
KR102587916B1 (en) * 2017-11-16 2023-10-11 (주)아모레퍼시픽 Cosmetic composition of water-in-silicone type containing organic UV absorbers

Also Published As

Publication number Publication date
SG11202110332WA (en) 2021-12-30
KR20200132142A (en) 2020-11-25
WO2020231036A1 (en) 2020-11-19

Similar Documents

Publication Publication Date Title
JP3515872B2 (en) Cosmetics
US6103245A (en) Topical barrier composition containing silicone and bentonite
JP3535389B2 (en) External composition
JP2003514840A (en) Powder-liquid composition
US11771640B2 (en) Water-in-oil emulsion cosmetic
TWI546082B (en) Skin Cosmetics
JP3515873B2 (en) Sunscreen cosmetics
JP5484710B2 (en) Water-in-oil emulsified base makeup cosmetic
JP5322394B2 (en) Solid powder cosmetic
TW202108116A (en) Sunscreen cosmetic composition having sebum absorbing ability
JP3073890B2 (en) Sebum-resistant powder and cosmetics containing it
JPH111411A (en) Silica/zinc oxide complex, its production and cosmetic formulated with the same
JP2019131499A (en) Skin external preparations or cosmetics
JP6462583B2 (en) Surface-treated powder using theanine and cosmetic containing the same
JP6985910B2 (en) Water-in-oil emulsified cosmetic
JP4637425B2 (en) Oily cosmetics
JP2000080021A (en) Ultraviolet absorbing pigment for cosmetic and cosmetic
JP2000119158A (en) Gel-like cosmetic
KR20200132710A (en) Sun screen composition comprising a complex formation of bis-ethylhexyloxyphenol methoxyphenyl triazine
JP2003277217A (en) Cosmetic
JP2001072532A (en) O/w-type emulsion cosmetic
JPH09183710A (en) Water-in-oil emulsion composition
JPH07258027A (en) Makeup cosmetic
JPH07258026A (en) Makeup cosmetic
JP2004137226A (en) Cosmetic